Effect of Sex Hormones on Plasma Phospholipid Fatty Acid Composition in Intact Rats and Rats With Bilaterally Occluded Carotid Arteries by Petrović, Snježana B. et al.
PHYSIOLOGICAL RESEARCH • ISSN 0862-8408 (print) • ISSN 1802-9973 (online) 
© 2014 Institute of Physiology v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic
Fax +420 241 062 164, e-mail: physres@biomed.cas.cz, www.biomed.cas.cz/physiolres
Physiol. Res. 63: 331-339, 2014 
Effect of Sex Hormones on Plasma Phospholipid Fatty Acid 
Composition in Intact Rats and Rats With Bilaterally Occluded 
Carotid Arteries 
S. PETROVIĆ1, M. TAKIĆ1, A. ARSIĆ1, V. VUČIĆ1, D. DRAKULIĆ2, M. MILOŠEVIĆ2,
M. GLIBETIĆ1
1Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, 
University of Belgrade, Belgrade, Serbia, 2Department of Molecular Biology and Endocrinology, 
Institute of Nuclear Sciences "Vinča", University of Belgrade, Belgrade, Serbia 
Received June 14, 2013 
Accepted November 8, 2013 
On-line February 24, 2014 
Summary 
The effects of 8-days treatment with 17α-estradiol (33.3 µg/kg) 
and progesterone (1.7 mg/kg) on plasma lipids and fatty acid 
composition of plasma phospholipids were examined in intact 
(INT) and bilaterally common carotid arteries occluded (BCO) 
male Wistar rats. Significant decrease of triglyceride level was 
found in BCO rats after the estradiol treatment. Both hormones 
elevated proportion of 18:1n-7 fatty acid in INT, but they failed 
to have such an effect in BCO. Estradiol increased 22:5n-3 and 
total n-3 polyunsaturated fatty acids (PUFA) in intact, and 
decreased 18:2n-6 in BCO rats. Significantly lower level of total 
n-3 was found in progesterone-treated than in estradiol-treated
BCO rats. Given that n-3 PUFA have many beneficial effects on
cell and tissue function, while n-6 PUFA have mostly the opposite
effects, estradiol, rather than progesterone, was seen to improve
plasma lipids and phospholipids FA profiles in INT and BCO
animals. Estradiol significantly elevated the estimated activity of
Δ9-desaturases and progesterone of Δ5-desaturase in BCO
group, with no effects in INT rats.
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Introduction 
Sex hormones are well known to influence lipid 
metabolism and fatty acid (FA) content in different 
mammal’s tissue such as liver, muscle, pancreas, arterial 
wall, adipose tissue and brain (D'Eon and Braun 2002, 
Oztekin et al. 2007, Irwin et al. 2008). Estrogen increases 
the activity of hormone sensitive lipase, leading to the 
rise in circulating FA (D'Eon and Braun 2002). On the 
other hand, progesterone counteracts this stimulatory 
effect of estrogen and reduces plasma free FA, mostly 
acting via phosphodiesterase IV and cAMP (Saleh et al. 
1999, Campbell and Febbraio 2001). In rats, estradiol 
decreases circulating total cholesterol and low density 
lipoproteins (LDL) level, and prevents LDL binding to 
the artery wall, while no cholesterol-lowering effect of 
progesterone was found (Lundeen et al. 1997, Walsh et 
al. 2000). Plasma triglycerides (TG) are also affected by 
estradiol. Brooks-Asplund et al. (2002) detected an 
estradiol-induced increase of plasma TG level in male 
lean and obese Zucker rats, the same effect was detected 
in ovariectomized female rats (Liu et al. 2004). In 
humans, estrogen therapy is associated with improved 
plasma lipoprotein profiles (McCrohon et al. 1999). 
There is plenty of evidence about beneficial role 
of female sex hormones in maintaining the structure and 
function of the nervous system when compromised by 
various brain damages and injuries (Simpkins et al. 2005, 
Gibson et al. 2006, Stein 2008). Due to poor blood 
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supply, bilateral occlusion of the common carotid arteries 
(BCO) in rats has been established as a model for chronic 
cerebral hypoperfusion and related neurodegenerative 
diseases (Farkas et al. 2007). BCO is closely associated 
with ischemic  derangement of the brain metabolism and 
neuronal energy failure, depletions of oxygen and ATP, 
generation of reactive oxygen species (ROS) and 
decrease of antioxidant enzymes activity, as well as with 
lipid peroxidation and damage of neuronal cell membrane 
(Farkas et al. 2007, Anil Kumar et al. 2011). Like in 
other pathophysiological conditions, sex steroid 
hormones, stimulate enzyme activity of antioxidant 
defense system, reduce intracellular ROS and alleviate 
lipid peroxidation, having a stabilizing effect on physical 
and functional properties of biomembranes following 
hypoxic-ischemic brain injury in BCO (Pajovic et al. 
2003, Irwin et al. 2008, Ozacmak and Sayan 2009, Ishrat 
et al. 2009). 
 Phospholipids (PL) are the major lipid 
components of cellular membranes in the brain as in the 
other tissues. Their FA compositions, together with 
membrane cholesterol content, significantly determine 
overall properties of biomembranes. Moreover, 
membrane fluidity depends on chain length, degree and 
type of unsaturation of PL fatty acids, as well as on the 
ratio between saturated and unsaturated fatty acids in PL 
(Tepsic et al. 2009). In pathological conditions, such as 
brain ischemia and metabolic stress caused by BCO, 
membrane PL precursors can be cleaved and released, 
possibly triggering peripheral lipid dysregulation (Quartu 
et al. 2012). Markers of lipid peroxidation have been 
found to be elevated in brain tissues and body fluids in 
neurodegenerative diseases (Anil Kumar et al. 2011). 
 This study was performed to assess the potential 
biochemical alternations in plasma lipids parameters and 
fatty acid composition of plasma phospholipids in intact 
and male rats with bilaterally occluded carotid arteries, 
subjected to short-term, 8-days, treatment with estrogen 
or progesterone. 
 
Material and Methods 
 
Animals and treatments 
 The experiments were carried out on 2 months 
old male Wistar rats. The animals were kept under 
controlled conditions, 12 h light-dark cycle, 22±2 °C, and 
had free access to water and food. Commercial normo-
protein pelted cereal-based diet (Veterinary Institute, 
Subotica) was applied, containing (w/w) 17.2 % protein, 
60.9 % carbohydrate, 3.7 % fat with polyunsaturated/ 
saturated fatty acid ratio (PUFA/SFA) of 1.3 and n-3/n-6 
PUFA ratio of 0.05, 5.6 % fiber and adequate amount of 
vitamins and minerals (ash 7.6 %). The animals were 
fasted overnight before decapitation. All experimental 
procedures were done according to our Institutional 
guidelines for animal research and principals of the 
European Convention for the Protection of Vertebrate 
Animals Used for Experimental and Other (Official Daily 
N.L 358/1-358/6, 18, December 1986). 
 For this study, rats were randomly divided into 
two main groups. The first group of twenty-one animals 
remained intact (INT). The second group, composed of 
26 animals was subjected to bilateral occlusion of the 
common carotid arteries (BCO). Rats were anesthetized 
with intraperitoneal administration of 400 mg/kg chloral 
hydrate. Midline cervical incision and blunt dissection of 
muscles were performed, exposing right and left common 
carotid arteries. Both arteries were permanently ligated 
with surgical thread, while leaving the vagus nerve intact. 
The survival rate was 80.8 %. 
 Both groups were divided into three subgroups 
(n=7) based on the treatment as follows. The first 
subgroup of animals of both INT and BCO groups 
received 33.3 µg/kg of 17α-estradiol (Sigma Chemical 
Co, St Louis, MO, USA) given in linseed oil (INT-E, 
BCO-E respectively). The second set of animals was 
treated with 1.7 mg/kg progesterone (Sigma Chemical 
Co, St Louis, MO, USA) in linseed oil (INT-P, BCO-P). 
The third set of animals received only vehicle, 0.2 ml of 
linseed oil (INT-V, BCO-V). Fatty acid composition of 
linseed oil was as follows (mol %): C16:0 6.74±0.10, 
C18:0 6.07±0.05, C18:1cis 18.69±0.08, C18:1trans 
1.29±0.03, C18:2n-6 13.59±0.13, C18:3n-3 53.63±0.31, 
SFA 12.81±0.08, MUFA 19.98±0.11, PUFA 67.21±0.19 
(Vucic et al. 2012). The first injection was applied 
30 min after surgery and the treatment was continued for 
8 consecutive days. After the treatment, animals were 
decapitated with Harvard Guillotine and blood samples 
(6-8 ml) from all rats were collected in tubes containing 
sodium citrate (3.8 % w/v) as anticoagulant. Samples 
were centrifuged at 1500 g for 10 min, and obtained 
plasma was immediately used for biochemical analysis. 
Remaining plasma was frozen at −80 °C until analysis of 
FA profiles.  
 
Biochemical analysis 
 Cholesterol, triglyceride, HDL-cholesterol and 
LDL-cholesterol in plasma were analyzed using the 
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automated enzymatic methods with cholesterol oxidase, 
glycerol oxidase, PEG modified cholesterol esterase and 
cholesterol esterase, respectively (Roche Diagnostics, 




Table 1. Weight gain of experimental animals. 
 
Subgroup Initial body weight (g) Final body weight (g) Body weight gain (g) 
INT-V 281 ± 26 305 ± 21 24 ± 2.3 
INT-E 319 ± 17 339 ± 24 20 ± 3.3 
INT-P 298 ± 19 319 ± 23 22 ± 2.1 
BCO-V 291 ± 20 309 ± 37 18 ± 2.4** 
BCO-E 300 ± 25 317 ± 44 17 ± 3.2 
BCO-P 310 ± 28 329 ± 45 19 ± 3.5* 
 
Values are means ± SD (g). * p<0.05 when compared INT-P and BCO-P. ** p<0.01 when compared INT-V and BCO-V. 
 
 
Analysis of plasma phospholipids fatty acid composition 
 Plasma lipids were extracted by the method of 
Folch et al. (1957) using a chloroform-methanol mixture 
(2:1 v/v). During the extraction procedure, lipids were 
protected against oxidation by addition of 10 mg / 100 ml 
2,6-di-tert-butyl-4-methylphenol (BHT) to the solvents. 
One-dimensional thin-layer chromatography (TLC) on 
Silica Gel GF plates (Merck, Darmstadt, Germany) using 
neutral lipid solvent system of hexane: diethyl ether: 
acetic acid (87:12:1) was applied to isolate PL fraction. 
Methyl esters of PL fatty acids were prepared by 
transmethylation, as described previously (Popovic et al. 
2012). 
 Fatty acids methyl esters were separated by Gas 
Chromatography (GC) using Shimadzu GC 2014 
(Shimadzu Co, Tokyo, Japan) equipped with a flame 
ionization detector and Rtx 2330 fused silica gel capillary 
column, (60 m x 0.25 mm x 0.2 µm) (Restek Co, 
Bellefonte, PA, USA). The flame ionization detector was 
set at 260 °C and the injection port at 220 °C, the oven 
temperature was programmed at 140 °C for 5 minutes 
and then from 140 °C to 220 °C at the heating rate 
3 °C/min. Individual FA methyl esters in the samples 
were identified by comparing sample peak retention times 
with authentic standards (Sigma Chemical Co, St Louis, 
MO, USA) and/or (PUFA)-2 standard mixture (Restek 
Co, Bellefonte, PA, USA). The results are expressed as 
percentages of total identified FA. 
 The activities of certain enzymes involved in FA 
biosynthesis, desaturases and elongases, were estimated 
as the product-to-precursor ratios of the percentages of 
individual FA. The ratio of 20:4n-6/20:3n-6 was used as a 
measure of estimated Δ5-desaturase. The 20:3n-6/18:2n-6 
ratio was used as a measure of Δ6-desaturase and 
elongase activities, while 16:1n-7/16:0 and 18:1n-9/18:0 
ratios represented estimated activities of Δ9-desaturase 1 
and 2, respectively. The index of elongase activity was 
calculated as the ratio 18:0/16:0. 
 
Statistical analysis 
 The results are expressed as means ± SD. The 
normal distribution of variables was tested using the 
Shapiro-Wilk test before statistical analysis. When 
variables showed normal distribution, statistical analysis 
was performed using one-way ANOVA, followed by 
Tukey post hoc test to identify differences between 
groups. For non-normally distributed variables, Kruskal-
Wallis and Mann-Whitney tests were applied (18:3n-3, 
22:4n-6 and MUFA). The differences were considered 




 As presented in Table 1, there were no 
statistically significant differences in body weight gains 
among -V, -E, -P subgroups in the same group (INT or 
BCO) but BCO-V and BCO-P rats had lower weight gain 
than the INT-V, e.g. INT-P groups. 
 Changes of biochemical parameters in plasma of 
estradiol-treated (INT-E) and progesterone-treated (INT-
P) intact rats are shown in Figure 1. In comparison with 
the control animals (INT-V), there were no significant 
effects of hormones on lipid profile. As in the case of 
intact animals, in rats with bilateral occluded carotid 
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arteries treatment with progesterone (BCO-P), as well as 
estradiol (BCO-E) slightly reduced total, HDL- and LDL- 
cholesterol, when compared to the control subgroup 
(BCO-V) (Fig. 2), but no statistical significance of 
differences between subgroups was found. Contrary to 
the intact rats, statistically significant decrease of 
triglyceride level after the estradiol treatment was found, 





Fig. 1. The effects of estrogen and progesterone on plasma 
total, HDL- and LDL- cholesterol and triglyceride levels (mmol/l) 
in intact rats (INT-V, white; INT-E, gray; INT-P, black). Data are 








Fig. 2. The effects of estrogen and progesterone on plasma 
total, HDL- and LDL- cholesterol and triglyceride levels (mmol/l) 
in rats with bilaterally occluded carotid arteries (BCO-V, white; 
BCO-E, gray; BCO-P, black). Data are the mean ± SD. * p<0.05 
when compared to the control rats (BCO-V). 
Table 2. The effects of estradiol and progesterone on plasma phospholipids fatty acid profile in intact (INT) rats and in rats with 
bilaterally occluded carotid arteries (BCO). 
 
Fatty acids INT-V INT-E INT-P BCO-V BCO-E BCO-P 
16:0 22.89 ± 1.94 22.43 ± 1.89 24.37 ± 2.54 22.74 ± 1.71 21.18 ± 2.07 24.19 ± 2.42 
16:1n-7 0.31 ± 0.10 0.30 ± 0.17 0.33 ± 0.12 0.23 ± 0.08 0.34 ± 0.20 0.21 ± 0.05 
18:0 23.71 ± 0.65 22.63 ± 3.09 22.84 ± 2.55 22.21 ± 1.63 21.74 ± 1.30 21.97 ± 1.14 
18:1n-9 5.00 ± 0.43 4.73 ± 0.17 5.06 ± 0.68 4.30 ± 0.30a 4.68 ± 0.43 4.30 ± 0.35 
18:1n-7 1.81 ± 0.07 2.39 ± 0.10*** 2.07 ± 0.29*# 1.59 ± 0.11a 1.64 ± 0.12 1.69 ± 0.11 
18:2n-6 24.83 ± 1.82 23.93 ± 3.18 24.59 ± 1.05 24.52 ± 1.90 21.55 ± 0.86* 22.53 ± 0.66 
18:3n-3 0.18 ± 0.06 0.15 ± 0.03 0.16 ± 0.04 0.34 ± 0.26 0.68 ± 0.53 0.22 ± 0.06 
20:3n-6 1.66 ± 0.16 1.47 ± 0.48 1.44 ± 0.31 1.68 ± 0.29 1.44 ± 0.26 1.21 ± 0.22* 
20:4n-6 13.35 ± 3.17 13.40 ± 2.75 12.14 ± 2.30 15.39 ± 2.82 19.14 ± 2.24 17.32 ± 1.01 
20:5n-3 0.82 ± 0.15 0.96 ± 0.21 0.80 ± 0.20 1.25 ± 0.41 0.92 ± 0.24 0.72 ± 0.06 
22:4n-6 0.34 ± 0.11 0.55 ± 0.30 0.30 ± 0.09 0.27 ± 0.04 0.26 ± 0.09 0.19 ± 0.08 
22:5n-3 1.40 ± 0.33 1.92 ± 0.49* 1.37 ± 0.29# 1.06 ± 0.32 1.06 ± 0.24 0.78 ± 0.10 
22:6n-3 4.18 ± 0.32 5.11 ± 0.74 4.53 ± 0.48 4.56 ± 1.08 5.37 ± 0.69 4.71 ± 0.36 
SFA 46.60 ± 2.37 45.06 ± 2.61 47.21 ± 1.73 44.95 ± 1.82 42.92 ± 2.88 46.16 ± 2.39 
MUFA 7.13 ± 0.43 7.41 ± 0.25 7.45 ± 1.03 6.12 ± 0.42a 6.65 ± 0.44 6.20 ± 0.46 
PUFA 46.77 ± 2.03 47.48 ± 2.64 45.33 ± 1.78 49.07 ± 2.28 50.42 ± 2.81 47.68 ± 2.12 
n-6 40.18 ± 2.02 39.35 ± 3.30 38.47 ± 1.63 41.86 ± 1.80 42.39 ± 2.23 41.24 ± 1.67 
n-3 6.58 ± 0.54 8.14 ± 1.08* 6.86 ± 0.81 7.21 ± 1.46 8.03 ± 1.13 6.44 ± 0.49# 
n-6/ n-3 6.14 ± 0.62 4.95 ± 1.09 5.67 ± 0.67 6.05 ± 1.45 5.36 ± 0.68 6.42 ± 0.28 
 
Values are means ± SD (mol %). SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. 
* p<0.05, *** p<0.001 – when compared to the proper hormone-untreated subgroup (INT-V or BCO-V). a p<0.05 when compared the 
INT-V subgroup. # p<0.05 – when compared to the proper estradiol-treated subgroup (INT-E or BCO-E), as determined by ANOVA 
followed by the Tukey post hoc test. 
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Table 3. The estimated plasma desaturase and elongase activities in intact rats and rats with bilateral occlusion of carotid arteries. 
 
Desaturases and elongases INT-V INT-E INT-P 
20:4n-6/20:3n-6 (Δ5) 8.13 ± 2.20 10.34 ± 4.75 8.88 ± 2.86 
20:3n-6/18:2n-6 (Δ6) 0.07 ± 0.01 0.06 ± 0.02 0.06 ± 0.01 
16:1n-7/16:0 (Δ9-1) 0.015 ± 0.003 0.014 ± 0.007 0.015 ± 0.002 
18:1n-9/18:0 (Δ9-2) 0.29 ± 0.02 0.33 ± 0.02 0.32 ± 0.07 
18:0/16:0 1.04 ± 0.08 1.02 ± 0.20 0.95 ± 0.19 
Desaturases and elongases BCO-V BCO-E BCO-P 
20:4n-6/20:3n-6 (Δ5) 9.35 ± 2.21 13.81 ± 3.52 14.47 ± 2.60* 
20:3n-6/18:2n-6 (Δ6) 0.07 ± 0.01 0.07 ± 0.01 0.05 ± 0.01 
16:1n-7/16:0 (Δ9-1) 0.009 ± 0.002a 0.020 ± 0.007* 0.009 ± 0.002 
18:1n-9/18:0 (Δ9-2) 0.26 ± 0.02a 0.29 ± 0.02* 0.28 ± 0.02 
18:0/16:0 0.98 ± 0.12 1.03 ± 0.09 0.92 ± 0.10 
 
a p<0.05 – when compared to intact hormone-untreated animals (INT-V), * p<0.05 – when compared to control group (BCO-V), as 
determined by ANOVA followed by the Tukey post hoc test. 
 
 
 Alternations in percentage of individual fatty 
acids observed in plasma phospholipids of control and 
hormone-treated intact and BCO rats are presented in 
Table 2. In comparison with INT-V, statistically 
significant increase in a monounsaturated fatty acid 
(MUFA), 18:1n-7 (vaccenic acid) was found in both INT-
E and INT-P subgroups. There was also a significant 
difference in vaccenic acid between INT-E and INT-P, 
showing a stronger raising effect of estradiol on this FA. 
The percentage of a polyunsaturated fatty acid (PUFA) 
22:5n-3 (eicosapentanoic acid, EPA) elevated 
significantly in estradiol-treated rats, but not in the INT-P 
subgroup, making a significant difference between EPA 
in INT-E and INT-P. These changes induced significant 
increase in total n-3 PUFA in INT-E. The relative fatty 
acid composition of plasma PL in rats with bilateral 
occlusion of carotid arteries was very slightly affected by 
estradiol or progesterone. Statistically significant 
decrease in linoleic acid (18:2n-6, LA) in estradiol-
treated subgroup (BCO-E) was found when compared to 
the control subgroup (BCO-V). In progesterone-treated 
subgroup (BCO-P), a significant decrease in dihomo-
gamma-linoleic acid (20:3n-6, DGLA) was detected in 
comparison to BCO-V, and also in total n-3 PUFA, when 
compared to BCO-E. All other FA remained unchanged 
in both treated groups. 
 Treatment with estradiol and progesterone did 
not significantly affect the estimated activity of 
desaturase and elongase systems in plasma phospholipids 
of intact rats (Table 3). In BCO rats, progesterone 
treatment increased the activity of Δ5-desaturase, while 
estradiol positively affected the estimated activity of Δ9-
desaturases 1 and 2. Moreover, hormone-untreated BCO 
rats (BCO-V) had significantly lower estimated activities 
of Δ9-desaturases 1 and 2, when compared to intact 
hormone-untreated animals (INT-V). There is also an 
upward trend of Δ5-desaturase activity in INT-E and 





 Short term hormone treatments applied in this 
study had no effect on body weight gains in both INT and 
BCO rats. A lower weight gains in all BCO subgroups, 
when compared to the corresponding INT subgroups, 
could be explained by discomfort which BCO animals 
felt during movement of the head, mastication, and 
swallowing in the first days after surgery (Farkas et al. 
2007). 
 Our results have shown that physiological 
concentration of steroid hormones 17α- estradiol and 
progesterone had no effect on plasma cholesterol level in 
intact 2 months old male rats and BCO rats. A significant 
modulatory effect of estradiol was found only on 
triglyceride level in BCO rats. In all (hormone-treated 
and untreated) BCO subgroups an elevated level of 
plasma triglycerides (TG) was found, when compared to 
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the appropriate INT subgroups. It suggests that bilateral 
occlusion of carotid arteries induced a sharp increase in 
plasma TG (1.26 mmol/l in INT-V vs. 1.74 mmol/l in 
BCO-V). Cerebral ischemia has already been reported to 
increase circulating TG in spontaneously hypertensive 
male and female rats subjected to BCO (Wexler 1980), 
that is in line with our results. However, in this study, 
short-term, 8 days, treatment with physiological doses of 
progesterone and 17α-estradiol did not affect plasma TG 
level in male intact rats, while estradiol decreased TG in 
rats with bilateral occlusion. Previous studies showed 
increasing effect of estradiol. It is possible that 
physiologic doses of estradiol mitigated the increase in 
TG after the operation in BCO rats. Namely, 
subcutaneously administered ovarian hormones for 
7 days alleviate stroke injury in reproductively senescent 
female rats (Alkayed et al. 2000). After the treatment of 
same duration physiologic doses of progesterone reduces 
mitochondrial dysfunction and hippocampal cell loss 
after traumatic brain injury in female rats (Robertson et 
al. 2006), while estradiol reduces cortical and caudate 
infarction volume in castrated male rats (Toung et al. 
1998). Therefore, physiologic doses of ovarian hormones 
induced significant changes in brain and it is possible that 
the same doses and duration of treatment affect lipid 
profile as well. 
 Even one-time to one-week hormone treatment 
decreases brain oxidative stress markers, increases 
endogenous antioxidant levels, reduces the extent of brain 
injury and promotes the neurogenesis after carotid 
occlusion, stroke and traumatic brain injury (Ozacmak 
and Sayan 2009, Barha et al. 2011, Zhang et al. 2013). At 
least some of these effects may be related to hormonal 
capability to attenuate increase of disintegration and 
decrease of resynthesize of membrane phospholipids 
following hypoxic-ischemic brain injury. Busto et al. 
(1989) assumed that ischemia induced fluctuations of 
palmitic, stearic, oleic and arachidonic acids in local 
cerebral blood flow, following increase in their 
concentrations detected in cortex and striatum of 
experimental rats. In addition, hormonal treatment could 
induce systemic changes in FA metabolism, which could 
be seen in plasma phospholipids, as examined in this 
paper. Although 8 days may be rather short time for the 
analyses of brain lipid metabolism, short-term estradiol 
and progesterone administration is very commonly used 
in treatment of different brain injuries, thus it is important 
to examine its possible effects on plasma lipids and 
phospholipids.  
 Bilateral occlusion of carotid arteries in rats led 
to a significant decline in plasma PL 18:1n-7 (vaccenic 
acid) and 18:1n-9 (oleic acid) content, and consequently 
in the concentration of total MUFA in BCO-V, when 
compared with intact control. It could be assumed that 
Δ9-desaturase activity was reduced in BCO rats. 
Although both estradiol and progesterone elevated 
proportion of vaccenic acid in intact rats, they failed to 
have such an effect in BCO groups. Estradiol also 
induced increases of 22:5n-3 (eicosapentanoic acid, EPA) 
and total n-3 PUFA in intact rats. Elevated concentrations 
of n-3 PUFA in rat plasma are positively associated with 
circulating concentrations of estradiol and progesterone 
(Childs et al. 2008). However, in our study progesterone 
had no effect on n-3 PUFA proportion in intact rats. 
Moreover, in BCO rats, significantly lower level of total 
n-3 was found in BCO-P than in the BCO-E subgroup. 
Given that n-3 PUFA have many beneficial effects on cell 
and tissue function, including anti-inflammatory, 
anticancer, cardioprotective and neuroprotective effects 
(Ristic-Medic et al. 2013), our results confirmed 
favorable effects of estradiol in intact animals. In BCO 
rats, estradiol significantly reduced linolenic acid (18:2n-
6), with no effect on MUFA or n-3 PUFA. Regarding that 
n-6 PUFA have mostly the opposite effects of n-3 FA 
(pro-inflammatory and pro-cancerogenic), the total effect 
of estradiol is beneficial in BCO animals as well.  
 As primarily observed in erythrocytes, there is a 
positive correlation between the alternations in plasma 
phospholipid composition and cell membranes (Peet et al. 
1998). The alternations in plasma n-3 and n-6 long-chain 
PUFA detected it this study, are expected to reflect on the 
phospholipid composition of the neuronal membrane, in a 
way that improves physicochemical environment to 
promote protein-lipid and protein-protein interactions 
essential for neuronal function, synaptic transmission and 
neurotransmitter signaling (Fabelo et al. 2011).  
 The sex hormones act to modify plasma and 
tissue PUFA content, possibly by altering the expression 
and activity of desaturase and elongase enzymes (Childs 
et al. 2008). In BCO animals, estimated activity of Δ9-
desaturases 1 and 2 was significantly lower than in the 
intact rats, as we previously assumed based on lower 
levels of MUFA. Furthermore, estradiol treatment 
significantly increased the activity of this enzyme in BCO 
rats (but not in intact ones), while progesterone elevated 
the estimated activity of Δ5-desaturase. In line with our 
results, Marks et al. (2013) have recently reported 
increased Δ9-desaturase 1 expression in HepG2 cells, 
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after 17β-estradiol treatment, although they also found 
decreased expression of this enzyme after treatment with 
progesterone. However, these alterations were not found 
when compared male and female rats. They also found 
elevated expression of hepatic elongase in females 
relative to male rats, which appears to be mediated by sex 
hormones based on observations of hormonal treatments 
of HepG2 cells (Marks et al. 2013). Nevertheless, both 
hormones had no significant effects on desaturase/ 
elongase in intact rats in our study, although we detected 
some alterations in FA profiles in these animals as well. 
In addition, we should not neglect other possible reasons 
for the observed changes in phospholipid fatty acid 
composition, including PUFA mobilization from the 
adipose tissue, phospholipids remodeling of brain tissue 
or effects of oxidative stress.  
 In summary, applied hormones induced different 
effects on FA in intact and BCO rats. Estradiol showed 
beneficial effect on FA composition in intact rats, 
increasing EPA and n-3 PUFA proportion, which are 
crucial for cardiovascular health and synthesis of anti-
inflammatory eicosanoids. In BCO rats, estradiol reduced 
level of LA, which is a precursor of n-6 arachidonic acid 
and pro-inflammatory eicosanoids. In contrast, 
progesterone showed no positive effects on plasma fatty 
acid profile. The possible reasons for overall weak effects 
of hormones include short term treatment and influence 
of endogenous testosterone. Thus, further investigations 
of longer duration on more animals should be required. 
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